Glucose Frequent of A1GDM in Labor

Description

This is a prospective double arm study in patients with Gestational Diabetes Mellitus (GDM) utilizing frequent (single fingerstick on admission) vs infrequent glucose monitoring in labor (q 4 hours in latent labor and every 2 hours in active labor). Primary Objective: The primary outcome is glucose value of the neonate at birth. Secondary Objectives: Determine rates of insulin requirements within different monitoring techniques. Determine if there is a difference in neonatal intensive care unit (NICU) admission within different monitoring techniques. Determine neonatal blood glucose concentrations at 24 hours of life, number of glucose treatments, and neonatal hyperbilirubinemia. Secondary characteristics to be viewed for each diagnosis; BMI, race, age, and parity.

Conditions

Gestational Diabetes, Controlled by Diet

Talk to us

Study Overview

On this page

Study Details

Study overview

This is a prospective double arm study in patients with Gestational Diabetes Mellitus (GDM) utilizing frequent (single fingerstick on admission) vs infrequent glucose monitoring in labor (q 4 hours in latent labor and every 2 hours in active labor). Primary Objective: The primary outcome is glucose value of the neonate at birth. Secondary Objectives: Determine rates of insulin requirements within different monitoring techniques. Determine if there is a difference in neonatal intensive care unit (NICU) admission within different monitoring techniques. Determine neonatal blood glucose concentrations at 24 hours of life, number of glucose treatments, and neonatal hyperbilirubinemia. Secondary characteristics to be viewed for each diagnosis; BMI, race, age, and parity.

Glucose Monitoring for A1GDM

Glucose Frequent of A1GDM in Labor

Condition
Gestational Diabetes, Controlled by Diet
Intervention / Treatment

-

Contacts and Locations

New York

Mount Sinai West, New York, New York, United States, 10019

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * All female patients of reproductive age (menarche-menopause: 18-51 years) who have the diagnosis diet controlled GDM
  • * Patient with singleton gestation presenting in labor or for induction
  • * Patients who had "good" glucose control and were A1GDM. Good Control;
  • * - Patient with overall outpatient glucose average of less than 100
  • * - No evidence of fetopathy, large for gestational age or polyhydramnios.
  • * - Hgb A1c \<5.7

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

Icahn School of Medicine at Mount Sinai,

Thomas Owens, MD, PRINCIPAL_INVESTIGATOR, Mount Sinai West

Study Record Dates

2025-07-01